Inicio › Cáncer de recto › Nueva York

Ensayos clínicos de Cáncer de recto en Nueva York

22 estudios sobre Cáncer de recto buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT05672524

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Ellis Hospital ( Site 0098), Schenectady

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06997497

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Columbia University Irving Medical Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07433673

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Montefiore Medical Center-Einstein Campus, The Bronx
James J Peters VA Medical Center, The Bronx

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07283939

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Reclutando

Edades de 45 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05080673

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
Memorial Sloan Kettering Cancer Center, New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04165772

Family Communications After Genetic Testing

Glens Falls Hospital, Glens Falls

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07143487

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07227636

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

NYU Langone Health Perlmutter Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

University of Rochester Medical Center, Rochester

ReclutandoFase 2

Edades de 18 a 100 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Weill Cornell Medical College, New York
Brooklyn Methodist Hospital - NewYork Presbyterian, New York
New York Presbyterian Hospital - Queens, New York

ReclutandoFase 2

Edades de 18 a 90 · Todos los sexos · Actualizado el 29 jul 2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
y 4 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT06205485

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
Weill Cornell Medical College, New York
New York Presbyterian Hospital - Queens, New York

Reclutando

Edades de 18 a 90 · Todos los sexos · Actualizado el 15 jun 2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NYU Langone Medical Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jun 2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 may 2026 · NCT06673329

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Memorial Sloan Kettering Cancer Center, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 mar 2026 · NCT04668872

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
y 2 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NYU Langone Health, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT06682793

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Bassett Healthcare Network, Cooperstown

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 mar 2023 · NCT04245683

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.